Fundraising Fox

WuXi PharmaTech

4 known investors

WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America. The company serves pharmaceutical innovators seeking to accelerate the development and manufacturing of new therapies in a cost-effective manner.

Advanced ManufacturingBiotechEnterprise SoftwareHealthtech

Investors · 4

Highlight CapitalNanjin · $2.8M – $74M
Huangpu River CapitalShanghai
Vivo CapitalPalo Alto · $10M – $50M
Legend CapitalreportedBeijing · $2.9M – $156Mvia Frank Hong · inferred

In the news

WuXi venture unit raises $290M for 'find in U.S., build in China' venture fund | Fierce Pharmafiercepharma.com · Dec 2015Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx | Fierce Biotechfiercebiotech.com · May 2015Phagelux Of China Raises Funds From WuXi PharmaTech Co., Ltd. - BioSpacebiospace.com · Mar 2014WuXi PharmaTech helps pump $42m into Ivenix - Global Venturingglobalventuring.com

Frequently asked questions

What does WuXi PharmaTech do?
WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America. The company serves pharmaceutical innovators seeking to accelerate the development and manufacturing of new therapies in a cost-effective manner.
Who are WuXi PharmaTech's investors?
WuXi PharmaTech's investors include Highlight Capital, Huangpu River Capital, Vivo Capital, Legend Capital.